Cardiotrophin-1 attenuates endotoxin-induced acute lung injury.

Cardiotrophin-1 (CT-1) is a recently discovered member of the gp130 cytokine family, which includes IL-6, IL-11, leukemia inhibitory factor, ciliary neurotrophic factor, and oncostatin M. Recent evidence suggests that, like other members of this family, CT-1 may possess anti-inflammatory properties. We hypothesized that in vivo CT-1 administration would attenuate endotoxin (ETX)-induced acute lung injury. We studied the effects of CT-1 (100 microgram/kg ip, 10 min prior to ETX) in a rat model of ETX-induced acute lung injury (Salmonella typhimurium lipopolysaccharide, 20 mg/kg ip). Six hours after ETX, lungs were harvested for determination of neutrophil accumulation (myeloperoxidase, MPO, assay) and lung edema (wet-to-dry weight ratio). Mechanisms of pulmonary vasorelaxation were examined in isolated pulmonary artery rings at 6 h by interrogating endothelium-dependent (response to acetylcholine) and endothelium-independent (response to sodium nitroprusside) relaxation following alpha-adrenergic (phenylephrine)-stimulated preconstriction. CT-1 abrogated the endotoxin-induced lung neutrophil accumulation: 2.3 +/- 0.2 units MPO/g wet lung (gwl) vs 6. 3 +/- 0.3 units MPO/gwl in the ETX group (P < 0.05 vs ETX, P > 0.05 vs control). Similarly, CT-1 prevented ETX-induced lung edema: wet-to-dry-weight ratio, 4.473 +/- 0.039 vs 4.747 +/- 0.039 in the ETX group (P < 0.05 vs ETX, P > 0.05 vs control). Endotoxin caused significant impairment of both endothelium-dependent and -independent pulmonary vasorelaxation, and CT-1 attenuated this injury. Thus, cardiotrophin-1 possesses significant anti-inflammatory properties in a model of endotoxin-induced acute lung injury.

[1]  N. Maekawa,et al.  Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. , 1998, Critical care medicine.

[2]  M. Sagy,et al.  A comparison among animal models of acute lung injury. , 1998, Critical care medicine.

[3]  A. Stephanou,et al.  Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. , 1998, Journal of molecular and cellular cardiology.

[4]  Y. Nagashima,et al.  Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. , 1998, Journal of immunology.

[5]  E. Deitch.  ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED , 1998, Shock.

[6]  N. Tamura,et al.  Endothelin-1 and cardiotrophin-1 induce brain natriuretic peptide gene expression by distinct transcriptional mechanisms. , 1998, Journal of cardiovascular pharmacology.

[7]  T. Hirano,et al.  Signaling mechanisms through gp130: a model of the cytokine system. , 1997, Cytokine & growth factor reviews.

[8]  H. Wong,et al.  The stress response and the lung. , 1997, The American journal of physiology.

[9]  K. Chien,et al.  Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development , 1997, Journal of Molecular Medicine.

[10]  S. Chevalier,et al.  Signaling of the Cardiotrophin-1 Receptor , 1997, The Journal of Biological Chemistry.

[11]  R. McIntyre,et al.  Endotoxin differentially impairs cyclic guanosine monophosphate-mediated relaxation in the pulmonary and systemic circulations. , 1997, Critical care medicine.

[12]  P. Ghezzi,et al.  Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells. , 1996, The American journal of pathology.

[13]  Arthur S Slutsky,et al.  Effects of the stress response in septic rats and LPS-stimulated alveolar macrophages: evidence for TNF-alpha posttranslational regulation. , 1996, American journal of respiratory and critical care medicine.

[14]  R. McIntyre,et al.  Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation. , 1996, The American journal of physiology.

[15]  A. Dorner,et al.  Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. , 1996, Journal of immunology.

[16]  S. Rockwell,et al.  IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. , 1996, Journal of immunology.

[17]  M. Cairo,et al.  Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats. , 1996, Blood cells, molecules & diseases.

[18]  B. Barton,et al.  Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model , 1996, Infection and immunity.

[19]  G. Fantuzzi,et al.  Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. , 1996, Blood.

[20]  K. Nakao,et al.  cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. , 1996, Biochemical and biophysical research communications.

[21]  W. Zapol,et al.  In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated-perfused rat lung. , 1995, The American journal of physiology.

[22]  P. Ghezzi,et al.  Ciliary Neurotrophic Factor Inhibits Brain and Peripheral Tumor Necrosis Factor Production and, When Coadministered with Its Soluble Receptor, Protects Mice From Lipopolysaccharide Toxicity , 1995, Molecular Medicine.

[23]  L. Carey,et al.  Endotoxin infusion in anesthetized sheep is associated with intrapulmonary sequestration of leukocytes that immunohistochemically express tumor necrosis factor‐α , 1995, Journal of leukocyte biology.

[24]  R. McIntyre,et al.  Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. , 1995, The American journal of physiology.

[25]  W. Wood,et al.  Cardiotrophin-1 , 1995, The Journal of Biological Chemistry.

[26]  P. Waring,et al.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Chien,et al.  Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Williams,et al.  Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. , 1994, The American journal of physiology.

[29]  A S Slutsky,et al.  Induction of the heat shock response reduces mortality rate and organ damage in a sepsis‐induced acute lung injury model , 1994, Critical care medicine.

[30]  Z. Ba,et al.  Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. , 1994, The American journal of physiology.

[31]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[32]  K. Albertine,et al.  Loss of endothelium-dependent vasodilation in the pulmonary vessels of sheep after prolonged endotoxin. , 1994, Journal of applied physiology.

[33]  M. Jordana,et al.  Polymorphonuclear leukocytes as a significant source of tumor necrosis factor-alpha in endotoxin-challenged lung tissue. , 1993, The American journal of pathology.

[34]  Daniel,et al.  Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. , 1993, The Journal of clinical investigation.

[35]  S. Peters,et al.  A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. , 1992, The American review of respiratory disease.

[36]  J. Norton,et al.  Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor , 1992, The Journal of experimental medicine.

[37]  B. Meyrick,et al.  Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor alpha. , 1991, The American review of respiratory disease.

[38]  J. Vilček,et al.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.

[39]  T. Raffin,et al.  Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. , 1988, The American review of respiratory disease.

[40]  N. Voelkel,et al.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. , 1987, The Journal of clinical investigation.

[41]  J. Repine,et al.  Neutrophils and Adult Respiratory Distress Syndrome , 1983, The Lancet.

[42]  B. Meyrick,et al.  Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure:function relationships. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[43]  F. Lewis,et al.  Cardiopulmonary parameters and prognosis after severe multiple trauma. , 1979, The Journal of trauma.

[44]  W. Zapol,et al.  Pulmonary hypertension in severe acute respiratory failure. , 1977, The New England journal of medicine.

[45]  K. Brigham,et al.  Effect of Increased Vascular Pressure on Lung Fluid Balance in Unanesthetized Sheep , 1975, Circulation research.